To give accurate information is our responsibly.
Australia is becoming an increasingly important destination for clinical research, particularly for Phase I, early-phase, oncology, rare disease, metabolic, radiopharmaceutical, cell and gene therapy, and …
Measles was once considered a disease that many countries were close to eliminating. In 2026, however, outbreaks are showing that progress can quickly reverse when …
Mpox vaccination is entering a more organized phase in 2026. The global response is moving from emergency donations and short-term vaccine allocation toward long-term stockpiles, …
Drug pricing in the U.S. is entering a new phase in 2026. The biggest change is no longer only about whether medicines are expensive. It …
The global vaccine industry is entering a different phase in 2026. COVID-19 vaccination is moving toward more targeted seasonal protection. Mpox has become a long-term …
Germany is becoming an increasingly important European hub for radiopharmaceuticals as cancer care moves toward molecular imaging, targeted radionuclide therapy, and theranostics. Public industry estimates …
The Brazil pharmaceutical contract manufacturing sector is gaining strategic importance as pharmaceutical companies seek scalable production, regulatory-compliant manufacturing, cost efficiency and access to established local …
What if CAR-T therapy no longer required collecting a patient’s immune cells, sending them to a specialized manufacturing facility, genetically engineering them, expanding them, testing …
Gene therapy in 2026 is entering a more commercially important phase. The industry is no longer asking whether genetic diseases can be treated by modifying …
BioNTech’s decision to terminate its Phase 2 colorectal cancer vaccine trial is an important warning for the mRNA oncology industry: promising technology alone does not …
by